Dr. Saravut J. Weroha, MD, PhD

  • Rochester, MN
  • Medical oncologist
NPI1043415144PAC ID5991864563
Medicare services, 2024
10,910
Medicare patients, 2024
196
Part D claims, 2024
156
Publications
73
Clinical trials
4
Practice address
1216 Second Street Southwest, Rochester, MN 55902
Practice phone
Call (507) 255-5123
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Mayo Clinic Hospital, Saint Marys Campus

Hospital · Rochester, Minnesota

See all 5 affiliations

Find Dr. Weroha's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Saravut J. Weroha is a medical oncologist in Rochester, Minnesota

Dr. Weroha practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Weroha's NPI, 1043415144, was assigned on June 19, 2007. Dr. Weroha graduated from University of Kansas School of Medicine in 2007. Dr. Weroha holds Minnesota license 51013.

NPI and contact details
Medicare PAC ID
5991864563
NPI enumeration date
June 19, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(507) 255-5123
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Saravut J. Weroha practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota

Dr. Weroha's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Source: Dmand AI Affiliation Data

Dr. Saravut J. Weroha is affiliated with 4 sites of care and 1 medical group

Dr. Weroha's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Weroha is also affiliated with Mayo Clinic Health System in Red Wing. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Weroha to 1 more hospital and 1 hospice, each named with a free account.

See all 5 affiliations for Dr. Weroha

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Saravut J. Weroha's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weroha practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Mayo Clinic Hospital, Saint Marys CampusAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Weroha practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Mayo Clinic and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Saravut J. Weroha is one of 122 medical oncologists in Minnesota

Medical oncology is Dr. Weroha's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Weroha is licensed in Minnesota.

Specialties and state licenses

  • Medical oncology, MinnesotaPrimaryLicense 51013 · taxonomy 207RX0202X

Clinical focus

Dmand AI lists breast cancer, lung cancer, lymphoma and purpura and thrombocytopenia among the conditions Dr. Weroha treats.

Medical oncologists near Dr. Weroha

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Saravut J. Weroha billed Medicare for 10,910 services in 2024

CMS data shows 10,910 Medicare services from Dr. Weroha across 20 procedure codes in 2024, for 196 Medicare patients. Medicare paid $313,270 for them. Every service was in an office.

Medicare services, 202410,910
Medicare patients196
Paid by Medicare$313,270
Procedure codes20

Dr. Weroha's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 14,8752024: 10,50629%
Tests and treatments
2023: 4312024: 34719%
Office and hospital visits
2023: 652024: 5712%

Dr. Weroha compared with the Minnesota median for medical oncologists, 2024

  • Dr. Weroha
  • Minnesota median
Medicare services
10,910vs 1,2848.5 times
Medicare patients
196vs 24821% below
Part D claims
109vs 19644% below

Medians across 119 medical oncologists in Minnesota with Dmand AI profiles that report each measure.

Dr. Weroha's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Weroha

Need commercial claims for Dr. Weroha?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Weroha and other medical oncologists in Minnesota.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Saravut J. Weroha treated 196 Medicare patients in 2024, average age 72

CMS counts 196 Medicare patients who saw Dr. Weroha in 2024. The largest group is 65 to 74, with 102 patients. 65% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weroha's median patient age at 67, with 78% women.

Medicare patients, 2024196
Average age72
Average risk score2.40
Also on Medicaid10%

Dr. Weroha's Medicare patients by age, 2024

Dr. Weroha's Medicare patients by sex, 2024

  • Women12564%
  • Men7136%

Chronic conditions among Dr. Weroha's Medicare patients, 2024

  1. High cholesterol65%
  2. High blood pressure64%
  3. Cancer49%
  4. Arthritis31%
  5. Anxiety24%
  6. Chronic kidney disease24%
  7. Depression20%
  8. Ischemic heart disease20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Weroha's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women78%
  • Men22%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Saravut J. Weroha wrote 156 Medicare Part D claims in 2024

In 2024, Dr. Weroha wrote 156 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 109 of them, across 4 drugs with 11 or more claims each, at $1,128 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

Part D claims, 2024156
Drugs named by CMS4
Total drug cost$1,128
Part D patients39

Dr. Weroha's Part D claims by kind of drug, 2024

  • Generic138 claims88%
  • Brand-name18 claims12%

Dr. Weroha's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Weroha's Part D claims, 2024

  • Antipsychotics, patients 65 and over10%16 of 156 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 192024: 109474%

Drugs named by CMS: 4 in 2024, 1 in 2023.

See all prescribing by Dr. Weroha

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Saravut J. Weroha offers telehealth to Medicare patients

Dr. Weroha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weroha as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Weroha by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Saravut J. Weroha has 73 publications on record

Dmand AI links 73 papers to Dr. Weroha, published from 2011 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Ovarian Neoplasms, Xenograft Model Antitumor Assays and Cell Line, Tumor. Dr. Weroha has published most often in Cancer Res. Dr. Weroha's most frequent co-authors are Paul Haluska, MD, Jamie N. Bakkum-Gamez, MD and Andrea Elisabeth Wahner Hendrickson, MD.

Papers73
Years published2011 to 2025

Dr. Weroha's papers by year, 2016 to 2025

Topics Dr. Weroha writes about most

  • Ovarian Neoplasms
  • Xenograft Model Antitumor Assays
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic
  • Antineoplastic Combined Chemotherapy Protocols
  • Signal Transduction
  • Antineoplastic Agents
  • Drug Resistance, Neoplasm

Dr. Weroha's most frequent co-authors

Recent publications by Dr. Weroha

See all 73 publications and co-authors

See who Dr. Weroha researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Weroha works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Saravut J. Weroha has worked on 4 clinical trials

Dmand AI links Dr. Weroha to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinoma, Ovarian Epithelial. Mayo Clinic sponsors the most, 2.

Clinical trials with Dr. Weroha by phase

  1. NonePhase 1: no trials
  2. 3Phase 2: 3 trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Weroha's trials

  • Fallopian Tube Diseases
  • Fallopian Tube Neoplasms
  • Carcinoma, Ovarian Epithelial
  • Cystadenocarcinoma
  • Cystadenocarcinoma, Serous

Investigators on the most trials with Dr. Weroha

Recent clinical trials with Dr. Weroha

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Saravut J. Weroha received $18,133 in industry payments from 2018 to 2025

CMS Open Payments shows 22 general payments to Dr. Weroha from 7 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $9,911. It also lists 1 research payment totaling $330 in 2023.

General payments to Dr. Weroha by program year, 2018 to 2025

General payments to Dr. Weroha by kind, 2018 to 2025

$18.1Kin total
  • Consulting fees$15,80987%
  • Travel and lodging$1,6169%
  • Food and beverage$7094%

Companies that paid Dr. Weroha the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Weroha

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Saravut J. Weroha graduated from University of Kansas School of Medicine

Dr. Weroha graduated from University of Kansas School of Medicine in 2007.

  1. Medical schoolUniversity of Kansas School of Medicine

Source: Dmand AI Professional Profile Data

Dr. Saravut J. Weroha accepts plans from 17 insurance carriers

Dr. Weroha is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Humana
  • Regence Health Plans
  • +9 more carriersWith a free account

Plan types Dr. Weroha accepts, by number of carriers

  1. PPO11
  2. Medicare9
  3. HMO6
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Saravut J. Weroha's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Saravut J. Weroha

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Saravut J. Weroha's NPI number?

Dr. Saravut J. Weroha's NPI number is 1043415144. It was assigned on June 19, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Saravut J. Weroha?

Dr. Saravut J. Weroha is a medical oncologist in Rochester, Minnesota. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Saravut J. Weroha practice?

Dr. Weroha practices at 1216 Second Street Southwest, Rochester, MN 55902. Dr. Weroha's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dmand AI also links Dr. Weroha to 1 hospital and 1 hospice.

What is Dr. Saravut J. Weroha's office phone number?

The practice phone on file for Dr. Weroha is (507) 255-5123.

What is Dr. Saravut J. Weroha's medical license number?

Dr. Weroha holds Minnesota license 51013.

Which hospitals is Dr. Saravut J. Weroha affiliated with?

Dr. Weroha practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota. Dr. Weroha is also affiliated with Mayo Clinic Health System in Red Wing. Dmand AI links Dr. Weroha to 1 more hospital.

What medical group is Dr. Saravut J. Weroha part of?

Dr. Weroha is linked to Mayo Clinic.

Does Dr. Saravut J. Weroha accept Medicare?

Yes. CMS data shows Dr. Weroha billed Medicare for 10,910 services in 2024, and Dr. Weroha accepts Medicare assignment.

Does Dr. Saravut J. Weroha offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Weroha as offering telehealth services.

How many Medicare patients does Dr. Saravut J. Weroha see?

CMS counts 196 Medicare patients who saw Dr. Weroha in 2024, with an average age of 72.

Show 8 more questionsShow fewer questions

What services does Dr. Saravut J. Weroha bill to Medicare?

In 2024, Dr. Weroha's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J9144) and injected or infused drug (J1453).

Where did Dr. Saravut J. Weroha go to medical school?

Dr. Weroha graduated from University of Kansas School of Medicine in 2007.

What drugs does Dr. Saravut J. Weroha prescribe most?

In 2024 Medicare Part D data, Dr. Weroha's most prescribed drugs by claims were Dexamethasone, Prochlorperazine Maleate and Ondansetron HCl.

Has Dr. Saravut J. Weroha received payments from drug or device companies?

CMS Open Payments shows $18,133 in general payments to Dr. Weroha from 7 companies from 2018 to 2025. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Saravut J. Weroha been practicing?

Dr. Weroha graduated from medical school in 2007, 19 years ago.

Does Dr. Saravut J. Weroha do research?

Dmand AI links 73 publications to Dr. Weroha, published from 2011 to 2025. Dr. Weroha has worked on 4 clinical trials.

Who does Dr. Saravut J. Weroha publish with?

Dr. Weroha's most frequent co-authors are Paul Haluska, MD (11 shared papers), Jamie N. Bakkum-Gamez, MD (9 shared papers) and Andrea Elisabeth Wahner Hendrickson, MD (7 shared papers).

What insurance does Dr. Saravut J. Weroha accept?

Dr. Weroha is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Minnesota by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)